Pneumeric, Inc. has partnered with JP Pharma to distribute Capnospot® Tension Pneumothorax Decompression Indicator in Brazil, which enables emergency responders to confirm proper needle placement quickly. Both companies aim to enhance pre-hospital care, with leaders from each expressing confidence in the partnership’s potential to save lives. Capnospot® offers real-time visual confirmation during decompression procedures, improving patient care.
Pneumeric, Inc. has formed a distribution agreement with JP Pharma to supply its Capnospot® Tension Pneumothorax Decompression Indicator in Brazil, allowing access to crucial emergency treatment devices for police, military, and medical responders. Capnospot® enhances patient care by providing visual confirmation of proper needle placement through a color change, enabling faster life-saving interventions.
JP Pharma, a leading supplier of tactical medical equipment in Latin America, collaborates with prestigious international medical device manufacturers. The addition of Capnospot® aligns with JP Pharma’s mission of improving pre-hospital care standards in Brazil and meets both companies’ strategic objectives.
Bruno Tavora, Chief Operating Officer of JP Pharma, expressed enthusiasm about the partnership, emphasizing their shared commitment to innovation. He stated the collaboration will enhance life-saving efforts in Brazil and uphold JP Pharma’s reputation for delivering advanced medical solutions. Deon Miller, Chief Commercial Officer of Pneumeric, expressed optimism about the partnership’s benefits, highlighting their shared goal of advancing medical technologies in the Brazilian market.
Capnospot® is designed to improve the precision of tension pneumothorax decompression procedures by delivering real-time visual validation, thereby supporting first responders in delivering critical care. Pneumeric, Inc., established in 2021, is dedicated to transforming tension pneumothorax management and has achieved FDA clearance with notable patents for the Capnospot® device.
Founded in 2008, JP Pharma focuses on providing high-quality medical equipment in Brazil, driven by a commitment to enhance healthcare through effective distribution and partnerships. For further details, visit their websites: Pneumeric at www.pneumeric-medical.com and JP Pharma at www.jppharma.com.br.
The distribution agreement between Pneumeric, Inc. and JP Pharma marks a significant advancement in emergency medical care in Brazil, facilitating the availability of the innovative Capnospot® device. This partnership underscores both companies’ commitment to enhancing the standards of pre-hospital care and effectively addressing critical medical needs. The collaboration is poised to save lives and improve patient outcomes in the region.
Original Source: www.prweb.com
